Standard BioTools
LAB
LAB
72 hedge funds and large institutions have $138M invested in Standard BioTools in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 19 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
16% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 19
16% less call options, than puts
Call options by funds: $83K | Put options by funds: $99K
Holders
72
Holding in Top 10
2
Calls
$83K
Puts
$99K
Top Buyers
| 1 | +$5.18M | |
| 2 | +$4.09M | |
| 3 | +$1.73M | |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$1.45M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$1.37M |
Top Sellers
| 1 | -$3.18M | |
| 2 | -$2.45M | |
| 3 | -$2.35M | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$1.72M |
| 5 |
D.E. Shaw & Co
New York
|
-$577K |